Odayme Quesada
- University of Cincinnati · Internal Medicine (NIH department code)
- The Christ Hospital · Obstetrics & Gynecology (topic-inferred)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #21,871
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8895454Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2026
Linked Award Amount
$833.4K
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#21,871
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Odayme Quesada as a PI. Multi-PI records show the full award amount for context.
- 1R01HL183368-01A1R01Contact PIEMbArK: Empagliflozin Treatment of Ischemic with Non-Obstructive Coronary Arteries (INOCA)University of Cincinnati · Internal Medicine (NIH department code)$734.3Kaward amount
- 5R03HL177034-02R03Contact PIIdentifying Inflammatory and Endothelial Mechanisms promoting Cardiac Deformation in Women with a History of PreeclampsiaThe Christ Hospital · Obstetrics & Gynecology (topic-inferred)$99.2Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Odayme Quesada as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Cincinnati
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding